CNS: Fenetresurcours: NewsRenderer
Group by:
Date (Most Recent First)
Industry
Subject
Region
Go
Today is June 30, 2024. All times in Eastern Daylight Time.
United States Home Infusion Therapy Market Analysis 2024: A $19+ Billion Industry by 2032 Featuring Baxter, BD and Co, Eli Lilly & Co, Fresenius, ICU Medical, Option Care Health, & Terumo - ResearchAndMarkets.com
06/28/2024 - 08:53 AM
DUBLIN--(BUSINESS WIRE)--The "United States Home Infusion Therapy Market Report by Application, Product, States and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's off...
more
»
Timor-Leste (East Timor) Telecoms, Mobile and Broadband Market Statistics and Analyses 2024 - ResearchAndMarkets.com
06/28/2024 - 08:53 AM
DUBLIN--(BUSINESS WIRE)--The "Timor-Leste (East Timor) Telecoms Market Report - Telecoms, Mobile and Broadband - Statistics and Analyses" report has been added to ResearchAndMarkets.com's offering....
more
»
Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
06/28/2024 - 08:50 AM
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten offering...
more
»
PGIM Introduces Two Active Muni ETFs
06/28/2024 - 08:47 AM
NEWARK, N.J.--(BUSINESS WIRE)--PGIM,2 the $1.34 trillion global investment management business of Prudential Financial, Inc. (NYSE: PRU), has launched two new actively managed exchange-traded funds...
more
»
Samenvatting: AQEMIA bereikt mijlpaal in het onderzoek naar een target die niet met geneesmiddelen behandelbaar is in immuno-oncologie in samenwerking met Servier
06/28/2024 - 08:46 AM
PARIJS--(BUSINESS WIRE)--AQEMIA, een toonaangevend bedrijf op gebied van ontdekking van geneesmiddelen op basis van generatieve AI, maakt bekend dat het een mijlpaal heeft bereikt in het onderzoek ...
more
»
Riassunto: AQEMIA raggiunge un importante traguardo in collaborazione con Servier nella ricerca immuno-oncologica sui bersagli inattaccabili
06/28/2024 - 08:46 AM
PARIGI--(BUSINESS WIRE)--AQEMIA, azienda leader nello sviluppo di nuovi farmaci grazie all’IA generativa, ha annunciato il raggiungimento di un importante traguardo nel contesto della sua collabora...
more
»
Resumen: AQEMIA logra con Servier un hito de investigación contra un objetivo no tratable en inmuno-oncología
06/28/2024 - 08:45 AM
PARÍS--(BUSINESS WIRE)--AQEMIA, empresa líder en el descubrimiento de fármacos basado en IA generativa, anuncia que ha alcanzado un hito en su colaboración con Servier, empresa farmacéutica interna...
more
»
Strategic Storytelling for Communications Conference 2024: Drive Employee Engagement, Shape Workplace Culture, and Influence Organizational Strategy (Washington, DC, United States - August 27-29 2024) - ResearchAndMarkets.com
06/28/2024 - 08:35 AM
DUBLIN--(BUSINESS WIRE)--The "Strategic Storytelling for Communications" conference has been added to ResearchAndMarkets.com's offering. Beyond brand, stories are critical to maintaining the human ...
more
»
Procaps Group Announces New Chairman
06/28/2024 - 08:31 AM
MIAMI & BARRANQUILLA, Columbia--(BUSINESS WIRE)--Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced th...
more
»
Blackstone Mortgage Trust Announces Second Quarter 2024 Earnings Release and Conference Call
06/28/2024 - 08:30 AM
NEW YORK--(BUSINESS WIRE)--Blackstone Mortgage Trust, Inc. (NYSE: BXMT) (the “Company”) today announced that it will publish its second quarter 2024 earnings presentation on its website at www.bxmt...
more
»
Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
06/28/2024 - 08:30 AM
FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
more
»
Graham Corporation Set To Join Russell 2000® and 3000® Indexes
06/28/2024 - 08:30 AM
BATAVIA, N.Y.--(BUSINESS WIRE)--Graham Corporation Set To Join Russell 2000® and 3000® Indexes
more
»
Almirall’s Ilumetri® (tildrakizumab) Restores and Maintains Wellbeing of Patients With Moderate-to-severe Plaque Psoriasis to the Levels of the General Population for up to 1 Year1
06/28/2024 - 08:30 AM
BARCELONA, Spain--(BUSINESS WIRE)--Almirall, a global pharmaceutical company dedicated to medical dermatology, announced today new data from the real-world evidence clinical study called “POSITIVE”...
more
»
Smart Packaging and Electronic Patient Information Training Course: Building Blocks for the Establishment and Delivery of e-PIL and SMART Strategic Initiatives (ONLINE EVENT: November 4-5, 2024) - ResearchAndMarkets.com
06/28/2024 - 08:29 AM
DUBLIN--(BUSINESS WIRE)--The "Smart Packaging and Electronic Patient Information Training Course" conference has been added to ResearchAndMarkets.com's offering. This course will provide the attend...
more
»
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
06/28/2024 - 08:21 AM
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 27.06.2024 GRDU.LN IE00...
more
»
1
...
14
15
16
17
18
19
20
21
22
23
24
...
930
« Previous
Next »
Get Business Wire News on Your Website
Terms of Use
|
© 2024 Business Wire